GSK2239633 FTIH Study

NCT01371812 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: GSK2239633
DRUG: Placebo

Sponsor

GlaxoSmithKline